Preventing Prostate Biopsy Complications: to Augment or to Swab?

Presenter Information

L. Glick, Thomas Jefferson UniversityFollow
S. Vincent, Thomas Jefferson University
T. M. Han, Thomas Jefferson University
C. Caputo, Thomas Jefferson UniversityFollow
D. Squadrito, Thomas Jefferson UniversityFollow
J. Y. Leong, Thomas Jefferson UniversityFollow
C. Fonshell, Health Care Improvement Foundation
K. Syed, Health Care Improvement Foundation
J. F. Danella, Geisinger Medical Center
S. Ginzburg, Einstein Healthcare Network
T. J. Guzzo, University of Pennsylvania - Center for Clinical Epidemiology and Biostatistics
M. Hagg, Midlantic Urology
J. D. Raman, Penn State Milton S. Hershey Medical Center
M. Smaldone, Fox Chase Cancer Center
R. G. Uzzo, Fox Chase Cancer Center
J. J. Tomaszewski, Cooper University
A. C. Reese, Temple University
E. J. Trabulsi, Thomas Jefferson UniversityFollow
L. G. Gomella, Thomas Jefferson UniversityFollow
M. J. Mann, Thomas Jefferson UniversityFollow

Start Date

5-28-2020 11:00 AM

End Date

5-28-2020 12:00 PM

Description

Aims for Improvement

• The aim of this study was to determine the antibiotic prophylaxis associated with the fewest infectious complications following prostate biopsy
• Determining the safest method allows the Jefferson Department of Urology to modify its biopsy protocol and improve the rate of post-biopsy complications

Keywords

Antibiotic Prophylaxis, Prostate Biopsy, Infection, Complications

Comments

Presented at the 2020 House Staff Quality Improvement and Patient Safety Conference